Market Share of Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Industry
The Latin America glucagon-like peptide-1 (GLP-1) agonists market is consolidated, with a few major manufacturers like Eli Lilly, AstraZeneca, Merck, Boehringer Ingelheim, and Novartis, etc. gaining presence in major countries while the remaining market comprises other local or region-specific manufacturers.
Latin America Glucagon-like Peptide-1 Agonists Market Leaders
AstraZeneca
Biocon
Novo Nordisk A/S
Eli Lilly and Company
Sanofi Aventis
*Disclaimer: Major Players sorted in no particular order
![Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market Concentration](https://s3.mordorintelligence.com/latin-america-glucagon-like-peptide-1-agonists-market/latin-america-glucagon-like-peptide-1-agonists-market_1679503458285_Latin_America_GLP_1_Market_Comp..webp)